• 1
    Longo DL, Young RC. Cosmetic talc and ovarian cancer. Lancet 1979; 2: 34951.
  • 2
    Rose DP, Boyar AP, Wynder EL. International comparison of mortality rates for cancer of the breast, ovary, prostate and colon and per capita food consumption. Cancer 1986; 58: 236371.
  • 3
    Cramer DW, Willett WC, Bell DA, Ng WG, Harlow BL, Welch WR, et al. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 1989; 2: 6671.
  • 4
    Whittemore AS, Wu ML, Paffenbarger RS, Sarles DL, Kampert JB, Grosser S, et al. Epithelial ovarian cancer and the ability to conceive. Cancer Res 1989; 49: 404752.
  • 5
    Negri E, Franceschi S, Tzonou A, Booth M, LaVecchia C, Parazzini F, et al. Pooled analysis of 3 European case–control studies: I. reproductive factors and risk of epithelial ovarian cancer. Int J Cancer 1991; 49: 506.
  • 6
    Piver S, Mettlin C, Tsukada Y, Nasca P, Greenwald P, McPhee ME. Familial ovarian cancer registry. Obstet Gynecol 1984; 64: 1959.
  • 7
    Lurain JR, Piver MS. Familial ovarian cancer. Gynecol Oncol 1979; 8: 18592.
  • 8
    Piver MS, Barlow JJ, Sawyer DM. Familial ovarian cancer: increasing in frequency? Obstet Gynecol 1982; 60: 397400.
  • 9
    Lynch HT, Bewtra C, Wells IC, Schuelke GS, Lynch JF. Hereditary ovarian cancer: clinical and biomarker studies. In: Lynch HT, Kullander S, editors. Cancer genetics in women. Boca Raton, FL: CRC Press, 1987: 4997.
  • 10
    Demographic Analysis Section, Division of Cancer Cause and Prevention, National Cancer Institute. Surveillance, epidemiology and end results: incidence and mortality data, 1973–77. U.S. Department of Health and Human Resources, National Institutes of Health, Public Health Service; publication no. 7386 and 7092. 1981.
  • 11
    Wu ML, Whittemore AS, Paffenbarger RS, Sarles DL, Kampert JB, Grosser S, et al. Personal and environmental characteristics related to epithelial ovarian cancer. Am J Epidemiol 1988; 128: 121627.
  • 12
    Kvale G, Heuch I, Nilssen S, Beral V. Reproductive factors in the risk of ovarian cancer: a prospective study. Int J Cancer 1988; 42: 24651.
  • 13
    The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. The reduction in risk of ovarian cancer associated with oral contraceptive use. N Engl J Med 1987; 316: 6505.
  • 14
    Hoover R, Gray LA, Fraumini JF. Stilbestrol and the risk of ovarian cancer. Lancet 1977; 2: 5334.
  • 15
    Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989; 44: 8339.
  • 16
    Jacobs I, Bast RC. The CA125 tumor-associated antigen: a review of the literature. Hum Reprod 1989; 4: 112.
  • 17
    VanNagell JR Jr., DePriest PD, Puls LE, Donaldson ES, Gallion HH, Pavlick EJ, et al. Ovarian cancer screening in asymptomatic postmenopausal women by transvaginal sonography. Cancer 1991; 68: 45862.
  • 18
    Tobacman JK, Tucker MA, Kase R, Greene MH, Costa J, Fraumeni JF Jr.. Intraabdominal carcinomatosis after prophylactic oophorectomy in ovarian cancer prone families. Lancet 1982; 2: 7957.
  • 19
    Lynch HT, Bewtra C, Lynch JF. Familial ovarian cancer: clinical nuances. Am J Med 1986; 81: 10736.
  • 20
    Lynch HT, Watson P, Bewtra C, Conway TA, Hippee CR, Kaur P, et al. Hereditary ovarian cancer: heterogeneity in age at diagnosis. Cancer 1991; 67: 146066.
  • 21
    Chen KTK, Schooley JF, Flam MS. Peritoneal carcinomatosis after prophylactic oophorectomy in familial ovarian cancer syndrome. Obstet Gynecol 1985; 66: 93S4S.
  • 22
    Menczer J, Ben-Baruch G. Familial ovarian cancer in Israeli Jewish women. Obstet Gynecol 1991; 77: 2767.
  • 23
    Lynch HT, Conway T, Lynch J. Hereditary ovarian cancer. In: Sharp F, Mason WP, Leake RE, editors. Ovarian cancer: biological and therapeutic challenges. New York: WW Norton, 1990: 719.
  • 24
    Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lynch J, et al. Familial breast-ovarian cancer locus on chromosome 17q12-q12. Lancet 1991; 338: 823.